Edition:
United States

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

4.83EUR
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
€4.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
292,777
52-wk High
€15.83
52-wk Low
€4.33

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.66 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 4 4 4
(2) OUTPERFORM 2 4 4 4
(3) HOLD 2 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 9.00 9.00 9.00 --
Year Ending Dec-17 6 53.29 99.90 22.80 80.86
Year Ending Dec-18 6 46.37 64.90 19.20 63.94
Earnings (per share)
Quarter Ending Dec-17 1 -0.66 -0.66 -0.66 --
Year Ending Dec-17 8 -0.05 0.88 -1.09 0.75
Year Ending Dec-18 7 -0.19 1.03 -1.10 0.47
LT Growth Rate (%) 1 -11.60 -11.60 -11.60 --

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 13.40 13.97 0.57 4.28

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 9.00 9.00 9.00 9.00 --
Year Ending Dec-17 53.29 53.29 56.56 63.72 80.86
Year Ending Dec-18 46.37 59.70 68.05 68.05 63.94
Earnings (per share)
Quarter Ending Dec-17 -0.66 -0.66 -0.52 -0.52 --
Year Ending Dec-17 -0.05 -0.05 0.11 0.16 0.75
Year Ending Dec-18 -0.19 -0.13 0.12 0.08 0.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 4
Year Ending Dec-18 0 1 1 4
Earnings
Quarter Ending Dec-17 0 0 0 1
Year Ending Dec-17 1 0 0 3
Year Ending Dec-18 0 0 0 2